SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Yasui, K. Fujiwara, M. Nakamura, T. Miyamura, Y. Yonemitsu, R. Mikata, M. Arai, T. Kanda, F. Imazeki, S. Oda, O. Yokosuka, Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B, Journal of Viral Hepatitis, 2015, 22, 2
  2. 2
    Shiv Kumar Sarin, Chandan Kumar Kedarisetty, Zaigham Abbas, Deepak Amarapurkar, Chhagan Bihari, Albert C. Chan, Yogesh Kumar Chawla, A. Kadir Dokmeci, Hitendra Garg, Hasmik Ghazinyan, Saeed Hamid, Dong Joon Kim, Piyawat Komolmit, Suman Lata, Guan Huei Lee, Laurentius A. Lesmana, Mamun Mahtab, Rakhi Maiwall, Richard Moreau, Qin Ning, Viniyendra Pamecha, Diana Alcantara Payawal, Archana Rastogi, Salimur Rahman, Mohamed Rela, Anoop Saraya, Didier Samuel, Vivek Saraswat, Samir Shah, Gamal Shiha, Brajesh Chander Sharma, Manoj Kumar Sharma, Kapil Sharma, Amna Subhan Butt, Soek Siam Tan, Chitranshu Vashishtha, Zeeshan Ahmed Wani, Man-Fung Yuen, Osamu Yokosuka, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014, Hepatology International, 2014, 8, 4, 453

    CrossRef

  3. 3
    Man-Fung Yuen, Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure, Hepatology International, 2014,

    CrossRef

  4. 4
    Xiaoguo Zhang, Yong An, Xuemei Jiang, Minling Xu, Linlin Xu, Shijun Chen, Yaguang Xi, Entecavir Versus Lamivudine Therapy for Patients With Chronic Hepatitis B-Associated Liver Failure: A Meta-Analysis, Hepatitis Monthly, 2014, 14, 11

    CrossRef

  5. 5
    Chien-Hung Chen, Chih-Lang Lin, Tsung-Hui Hu, Chao-Hung Hung, Po-Lin Tseng, Jing-Houng Wang, Juan-Yu Chang, Sheng-Nan Lu, Rong-Nan Chien, Chuan-Mo Lee, Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation, Journal of Hepatology, 2014, 60, 6, 1127

    CrossRef

  6. 6
    Hamid Ullah Wani, Saad Al Kaabi, Manik Sharma, Rajvir Singh, Anil John, Moutaz Derbala, Muneera J. Al-Mohannadi, High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B, Hepatitis Research and Treatment, 2014, 2014, 1

    CrossRef

  7. 7
    Junshuai Wang, Ke Ma, Meifang Han, Wei Guo, Jiaquan Huang, Daofeng Yang, Xiping Zhao, Jiangxin Song, Deying Tian, Junying Qi, Yuancheng Huang, Qin Ning, Nucleoside analogs prevent disease progression in HBV-related acute-on-chronic liver failure: validation of the TPPM model, Hepatology International, 2014, 8, 1, 64

    CrossRef

  8. 8
    Yang Xiang-hui, Xiao Lang, Zhang Yan, Zhang Li, Shi Xiao-feng, Ren Hong, Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: Using virologic response at week 4, European Journal of Internal Medicine, 2014, 25, 9, 860

    CrossRef

  9. 9
    Jing Lai, Chao-Shuang Lin, Lin Yang, Shu-Ru Chen, Ye-Qiong Zhang, Wei-Min Ke, Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failure, Clinics and Research in Hepatology and Gastroenterology, 2014, 38, 3, 331

    CrossRef

  10. 10
    Fa-Ling Wu, Ke-Qing Shi, Yong-Ping Chen, Martin Braddock, Hai Zou, Ming-Hua Zheng, Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review, Expert Review of Gastroenterology & Hepatology, 2014, 8, 6, 623

    CrossRef

  11. 11
    Jing Lai, Hai-xia Sun, Yu-sheng Jie, Ka Zhang, Wei-min Ke, Serum HBsAg level and its clinical significance in lamivudine treatment for patients with HBeAg-negative acute-on-chronic liver failure, International Journal of Infectious Diseases, 2014, 22, 78

    CrossRef

  12. 12
    Kama A. Wlodzimirow, Saeid Eslami, Ameen Abu-Hanna, Martin Nieuwoudt, Robert A. F. M. Chamuleau, A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality, Liver International, 2013, 33, 1
  13. 13
    Kama Wlodzimirow, Ameen Abu-Hanna, Robert A.F.M. Chamuleau, Acute-on-chronic liver failure – Its definition remains unclear, Journal of Hepatology, 2013, 59, 1, 190

    CrossRef

  14. You have free access to this content14
    Ankur Jindal, Manoj Kumar, Shiv K. Sarin, Management of acute hepatitis B and reactivation of hepatitis B, Liver International, 2013, 33,
  15. 15
    Lin Zhang, Chun-Qiu Hao, Jiang-Fu Liu, Meng Wang, Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B, Virology Journal, 2013, 10, 1, 134

    CrossRef

  16. 16
    Jing Lai, Ying Yan, Li Mai, Yu-Bao Zheng, Wei-Qiang Gan, Wei-Min Ke, Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure, Hepatobiliary & Pancreatic Diseases International, 2013, 12, 2, 154

    CrossRef

  17. 17
    Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, Acute-on-chronic liver failure in chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2012, 27, 4
  18. 18
    Rong-Rong Zhou, Hong-Bo Liu, Jian-Ping Peng, Yan Huang, Ning Li, Mei-Fang Xiao, Haichao Wang, Xue-Gong Fan, High mobility group box chromosomal protein 1 in acute-on-chronic liver failure patients and mice with ConA-induced acute liver injury, Experimental and Molecular Pathology, 2012, 93, 2, 213

    CrossRef

  19. 19
    Tianyan Chen, Yingli He, Xiaojing Liu, Zhi Yan, Ke Wang, Hongli Liu, Shuling Zhang, Yingren Zhao, Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure, Clinical and Experimental Medicine, 2012, 12, 3, 159

    CrossRef

  20. 20
    Song Zhai, Li Zhang, Shuangsuo Dang, Yong Yu, Zigang Zhao, Wenxue Zhao, Layang Liu, The Ratio of Th-17 to Treg Cells is Associated with Survival of Patients with Acute-on-Chronic Hepatitis B Liver Failure, Viral Immunology, 2011, 24, 4, 303

    CrossRef